You just read:

Asia-Pacific Hemophilia A and B Therapeutics in Markets to 2022: Market will be Valued at $699.1m and $112.9m Respectively in 2022, Growing from $444.9m and $76.3m in 2015, at CAGR of 6.7% and 5.8% - Research and Markets

News provided by

Research and Markets

Dec 08, 2016, 07:10 ET